Clinical Trial Update: The Liquid Embolic Agent for the Treatment of Brain Arteriovenous Malformation [NA]

View source ↗

Summary

An ongoing clinical trial evaluating a liquid embolic agent for treating brain arteriovenous malformation, sponsored by MicroPort NeuroTech, currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arteriovenous Fistula
• Brain Arteriovenous Malformation

Drugs mentioned

• Liquid Embolic Agent

Snippet

Sponsor: MicroPort NeuroTech Co., Ltd. | Conditions: Brain Arteriovenous Malformation, Arteriovenous Fistula | NA | Status: RECRUITING